Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Patient characteristics

From: HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia

SexWPSS risk groupBlood cellsPrimitive cells
Auer rodNo. of monocytes
Patient 361MaleHighDecrease18Positive0.8 × 109/L
Patient 765MaleVery highDecrease13Positive0.7 × 109/L
Patient 163MaleVery highDecrease15Positive0.4×109/L